To identify potential drugs and compounds that can be used for IBD treatment, we first selected the over- and under-expressed genes between control and DSS treatment groups in WT and Cgas-/- mice as a disease signature, and then used these signatures to query in CLUE platform, respectively. The gene discussed is CGAS; the disease is irritable bowel syndrome.